- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 75.96M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 79.84M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2025 | 80.15M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2025 | 80.12M sh |
| Shares Diluted | Q1 2026 · Sep 30, 2025 | 80.16M sh |
| Shares Diluted | Q1 2026 · Jun 30, 2025 | 80.15M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 79.99M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2024 | 79.7M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2024 | 70.66M sh |
| Shares Diluted | Q1 2026 · Sep 30, 2024 | 68.93M sh |
| Shares Diluted | Q1 2026 · Jun 30, 2024 | 67.11M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2024 | 66.84M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $20.97M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $27.71M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $23.67M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $1.25B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $1.28B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $28.55M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $40.74M |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2025 | $25.32M |
| Cash And Equivalents restated | Q1 2026 · Dec 31, 2024 | $21.99M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $569.52M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $627.78M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.71B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.77B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.47B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.6B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.33 |
| Eps Diluted | Q1 2026 · Dec 31, 2025 | −$0.01 |
| Eps Diluted | Q1 2026 · Dec 31, 2025 | −$0.08 |
| Eps Diluted | Q1 2026 · Sep 30, 2025 | −$0.04 |
| Eps Diluted | Q1 2026 · Jun 30, 2025 | $0.04 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.07 |
| Eps Diluted | Q1 2026 · Dec 31, 2024 | $0.26 |
| Eps Diluted | Q1 2026 · Dec 31, 2024 | $0.34 |
| Eps Diluted | Q1 2026 · Sep 30, 2024 | −$0.12 |
| Eps Diluted | Q1 2026 · Jun 30, 2024 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2024 | $0.17 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.33 |
| Eps Basic | Q1 2026 · Dec 31, 2025 | −$0.01 |
| Eps Basic | Q1 2026 · Dec 31, 2025 | −$0.08 |
| Eps Basic | Q1 2026 · Sep 30, 2025 | −$0.04 |
| Eps Basic | Q1 2026 · Jun 30, 2025 | $0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.07 |
| Eps Basic | Q1 2026 · Dec 31, 2024 | $0.26 |
| Eps Basic | Q1 2026 · Dec 31, 2024 | $0.34 |
| Eps Basic | Q1 2026 · Sep 30, 2024 | −$0.12 |
| Eps Basic | Q1 2026 · Jun 30, 2024 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2024 | $0.17 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.72M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $7.16M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$23.16M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.81M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $11.63M |
| Operating Income | Q1 2026 · Dec 31, 2025 | $15.92M |
| Operating Income | Q1 2026 · Dec 31, 2025 | $48.54M |
| Operating Income | Q1 2026 · Sep 30, 2025 | $11.14M |
| Operating Income | Q1 2026 · Jun 30, 2025 | $13.63M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $7.86M |
| Operating Income | Q1 2026 · Dec 31, 2024 | $29.53M |
| Operating Income | Q1 2026 · Dec 31, 2024 | $59.23M |
| Operating Income | Q1 2026 · Sep 30, 2024 | $13.71M |
| Operating Income | Q1 2026 · Jun 30, 2024 | $5.51M |
| Operating Income restated | Q1 2026 · Mar 31, 2024 | $10.48M |